Chapter 23 — Key Takeaways

What you should leave Chapter 23 with

1. Aryl halides resist SN1 and SN2 because (a) backside attack on sp² C is geometrically blocked, and (b) the phenyl cation is too unstable for SN1.

2. Three alternative aromatic substitution mechanisms exist: - SNAr (addition-elimination): for EWG-activated aryl halides + nucleophile. - Benzyne (elimination-addition): for non-activated aryl halides + very strong base. - SRN1 (radical): rare, specialized cases.

3. SNAr mechanism: - Step 1: nucleophile adds to ring C bearing the LG; sp³ C; Meisenheimer complex (negative-charge intermediate). - Step 2: leaving group departs; ring rearomatizes.

4. Required conditions for SNAr: strong electron-withdrawing group ortho or para to the leaving group. -NO₂ is the classic activator. Multiple EWGs accelerate the reaction.

5. Reactivity order of leaving groups in SNAr: F > Cl > Br > I (opposite to SN1/SN2). Why? Step 1 (attack) is rate-determining; F's electronegativity makes the ring C most electrophilic.

6. Position matters: meta-EWGs cannot stabilize the Meisenheimer (resonance doesn't reach meta carbons). Only o- and p-EWGs activate SNAr.

7. Benzyne mechanism: - Step 1: very strong base (NaNH₂, NaH) deprotonates ortho-H. - Step 2: carbanion expels leaving group → benzyne (strained alkyne-like ring intermediate). - Step 3: nucleophile adds to benzyne (either carbon) → mixture of isomers. - Step 4: protonation gives the substituted aromatic product.

8. Benzyne diagnostic: gives a mixture of regioisomers (because nucleophile can add to either of the two equivalent carbons of the strained π bond). Confirmed by Roberts' 1953 isotope labeling experiment.

9. Substituent effects on benzyne addition: nucleophile prefers to land at the carbon farther from a directing substituent (electronic and steric).

10. Modern benzyne generation: Kobayashi protocol (2-(trimethylsilyl)phenyl triflate + CsF) is mild and is now the method of choice.

11. Side-chain reactions target the benzylic carbon (next to the ring):

    • Halogenation (Br₂ + light, or NBS): radical; favored because benzyl radical is resonance-stabilized (~88 kcal/mol C-H bond).
    • Oxidation (KMnO₄ + heat): converts any alkyl with benzylic H to -COOH; chain length doesn't matter; tertiary benzylic without H is inert.

12. Conditions distinguish ring vs side chain:

    • Br₂ + Lewis acid (FeBr₃) → EAS, ring substitution.
    • Br₂ + light (or NBS) → radical, side chain halogenation.

13. Birch reduction: benzene → 1,4-cyclohexadiene using Na/NH₃/ROH. Selectivity for 1,4-product (kinetic) reflects the radical anion's protonation pattern at para position.

14. Substituent effects on Birch:

    • Donor (e.g., -OMe): H adds to the carbons not bearing the donor (donor stays on sp²).
    • Acceptor (e.g., -COOH): H adds at the C with the acceptor (acceptor on sp³).

15. Aryl Grignards/lithiums: Ar-MgX or Ar-Li from Ar-X + Mg or Li. Useful aryl carbon nucleophiles for additions to aldehydes, ketones, CO₂, etc.

16. Modern alternatives: Pd-catalyzed cross-coupling (Buchwald-Hartwig amination, Suzuki, etc., Ch 37) replaces SNAr/benzyne for non-activated substrates with milder conditions.

17. The aromatic substitution toolkit consists of:

    • EAS (Ch 21): electron-rich ring + electrophile.
    • SNAr (Ch 23): EWG-activated aryl halide + nucleophile.
    • Benzyne (Ch 23): strong base + non-activated aryl halide.
    • Pd cross-coupling (Ch 37): mild and versatile.
    • Benzylic chemistry (Ch 23): radical halogenation; oxidation to -COOH.
    • Birch reduction (Ch 23): partial reduction.

18. Industrial relevance (Case Study 1 + 2):

    • Imatinib (Gleevec) and other kinase inhibitors → SNAr on pyrimidine.
    • Sulfa drugs → SNAr-related chemistry on activated aryl halides.
    • Sanger reagent (DNFB) → SNAr for protein N-terminal sequencing (Nobel Prize 1958).
    • Terephthalic acid (PET plastic precursor; ~80 million tons/year) → side-chain oxidation of p-xylene.
    • Phthalic anhydride (plasticizers) → side-chain oxidation of o-xylene.

19. Pharmaceutical relevance: SNAr is a workhorse for kinase inhibitors and other heterocyclic drugs; it tolerates many functional groups, gives predictable regiochemistry, and is the "first-choice" method when the substrate is activated.

20. Mastery of Chapter 23 completes the aromatic chemistry toolkit. Combined with Chapters 20, 21, 22, you should be able to look at any aromatic compound and predict (1) whether and how it will undergo substitution, (2) where the substitution will occur, and (3) what mechanism applies.

Cross-references

• Chapter 18 — Radicals (foundation for benzylic radical halogenation).
• Chapter 20 — Aromaticity (foundation; pyridine/pyrimidine activate SNAr).
• Chapter 21 — EAS (complement: opposite mechanism, opposite substituent effects).
• Chapter 22 — Substituent effects (EWGs activate SNAr while deactivating EAS — reversed roles).
• Chapter 25 — Carbonyl additions (aryl Grignards + carbonyl).
• Chapter 30 — Amines (aniline from benzyne; SNAr-based aniline synthesis).
• Chapter 35 — Drug design (SNAr in kinase inhibitor synthesis).
• Chapter 37 — Pd cross-coupling (modern alternative to SNAr).
• Appendix C — Reaction summary.
• Appendix F — Named reactions (Sandmeyer, Birch, Bamberger, Sanger).

Study tip

For each aromatic substitution problem, ask three questions:

1. What's on the ring? - Activator → use EAS (Ch 21). - EWG ortho/para to LG → use SNAr (Ch 23). - No EWG; just LG → SNAr won't work; consider benzyne (Ch 23) or Pd coupling (Ch 37).

2. What's the reagent? - Electrophile → EAS. - Nucleophile → SNAr or benzyne. - Radical/light → benzylic position. - Strong oxidant → side-chain oxidation. - Na/NH₃/ROH → Birch reduction.

3. What's the position? - Ring → EAS or SNAr (depending on substrate). - Side chain (benzylic C) → radical halogenation or KMnO₄ oxidation.

If you can answer (1)-(3) correctly for any aromatic substitution problem, you have mastered Part V. The aromatic chemistry framework is now complete; Part VI (carbonyl chemistry, Ch 24-31) builds on this foundation.